|
Anxiety Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Additionally, we examined the association of SLC2A9 rs6855911 variant with anxiety disorders.
|
24204615 |
2013 |
|
Arteriopathic disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Genotypes of single nucleotide polymorphisms (SNPs) distributed across the SLC2A9 gene were obtained in the Genetic Epidemiology Network of Arteriopathy cohorts.
|
21186168 |
2011 |
|
Arteriosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Because polymorphisms are distributed randomly at mating (Mendelian randomization), studies based on GLUT9 polymorphisms may provide unconfounded assessment of the nature of the link between uric acid and atherosclerosis.
|
25301104 |
2015 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.
|
18327256 |
2008 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.
|
17997608 |
2007 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
|
18834626 |
2008 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
|
18327257 |
2008 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.
|
20884846 |
2010 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Identification of low-frequency variants associated with gout and serum uric acid levels.
|
21983786 |
2011 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
|
23263486 |
2013 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
|
23263486 |
2013 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele.
|
21768215 |
2011 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
|
18179892 |
2008 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.
|
20884846 |
2010 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.
|
25646370 |
2016 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.
|
27899376 |
2017 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.
|
31289104 |
2019 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Genetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean population.
|
26552468 |
2015 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders.
|
19723617 |
2010 |
|
Arthritis, Gouty
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.
|
30181573 |
2018 |
|
Atherosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Because polymorphisms are distributed randomly at mating (Mendelian randomization), studies based on GLUT9 polymorphisms may provide unconfounded assessment of the nature of the link between uric acid and atherosclerosis.
|
25301104 |
2015 |
|
Benign Prostatic Hyperplasia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Intracellular urate levels decreased in all prostate pathologies, while GLUT9 expression decreased in benign prostatic hyperplasia, prostatitis and high-grade prostate cancer.
|
26910779 |
2016 |
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Cardiovascular Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
As in adults, genetic variation in SLC2A9 is associated with serum uric acid concentrations, an important biomarker of renal and cardiovascular disease risk, in Hispanic children.
|
25833971 |
2015 |
|
Cardiovascular Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
These findings also enable us to propose a physiological model of the renal urate reabsorption via GLUT9 and URAT1 and can lead to a promising therapeutic target for gout and related cardiovascular diseases.
|
22132964 |
2011 |